Aviva PLC Takes $1.49 Million Position in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Posted by Defense World Staff on Feb 26th, 2023

Aviva PLC bought a new position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS – Get Rating) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 24,635 shares of the semiconductor company’s stock, valued at approximately $1,492,000. Aviva PLC owned approximately 0.07% of Axcelis Technologies as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently bought and sold shares of ACLS. Victory Capital Management Inc. raised its stake in shares of Axcelis Technologies by 1,590.4% during the 3rd quarter. Victory Capital Management Inc. now owns 343,666 shares of the semiconductor company’s stock worth $20,813,000 after purchasing an additional 323,335 shares in the last quarter. Goldman Sachs Group Inc. raised its position in Axcelis Technologies by 52.1% during the second quarter. Goldman Sachs Group Inc. now owns 450,517 shares of the semiconductor company’s stock worth $24,706,000 after acquiring an additional 154,258 shares in the last quarter. Prudential Financial Inc. lifted its stake in Axcelis Technologies by 195.8% in the first quarter. Prudential Financial Inc. now owns 201,281 shares of the semiconductor company’s stock valued at $15,202,000 after acquiring an additional 133,245 shares during the last quarter. Allianz Asset Management GmbH grew its position in shares of Axcelis Technologies by 138.6% in the 3rd quarter. Allianz Asset Management GmbH now owns 220,486 shares of the semiconductor company’s stock valued at $13,353,000 after acquiring an additional 128,080 shares during the period. Finally, LSV Asset Management increased its stake in shares of Axcelis Technologies by 58.8% during the 3rd quarter. LSV Asset Management now owns 301,100 shares of the semiconductor company’s stock worth $18,235,000 after purchasing an additional 111,548 shares during the last quarter. 86.47% of the stock is owned by institutional investors and hedge funds.

Axcelis Technologies Stock Performance

ACLS opened at $123.47 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.54 and a quick ratio of 2.56. The business has a fifty day simple moving average of $103.10 and a 200 day simple moving average of $80.26. Axcelis Technologies, Inc. has a 1 year low of $46.41 and a 1 year high of $129.71. The company has a market capitalization of $4.06 billion, a PE ratio of 22.61 and a beta of 1.76.

Axcelis Technologies (NASDAQ:ACLS – Get Rating) last announced its earnings results on Thursday, February 9th. The semiconductor company reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.46 by $0.25. Axcelis Technologies had a net margin of 19.90% and a return on equity of 30.16%. The company had revenue of $266.05 million during the quarter, compared to analysts’ expectations of $251.80 million. During the same quarter in the previous year, the business posted $1.05 earnings per share. Axcelis Technologies’s quarterly revenue was up 29.3% on a year-over-year basis. Research analysts expect that Axcelis Technologies, Inc. will post 5.55 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on ACLS. Benchmark lifted their price target on Axcelis Technologies from $103.00 to $142.00 and gave the stock a “buy” rating in a report on Friday, February 10th. Craig Hallum lifted their target price on Axcelis Technologies from $113.00 to $140.00 and gave the stock a “buy” rating in a research note on Friday, February 10th. Needham & Company LLC increased their price target on Axcelis Technologies from $100.00 to $140.00 and gave the company a “buy” rating in a research note on Friday, February 10th. DA Davidson raised their price target on Axcelis Technologies from $105.00 to $145.00 and gave the company a “buy” rating in a report on Friday, February 10th. Finally, StockNews.com downgraded shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a report on Wednesday, December 28th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $144.40.

Insiders Place Their Bets

In other news, EVP Douglas A. Lawson sold 350 shares of the firm’s stock in a transaction that occurred on Monday, November 28th. The shares were sold at an average price of $76.52, for a total transaction of $26,782.00. Following the transaction, the executive vice president now directly owns 34,038 shares of the company’s stock, valued at $2,604,587.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Axcelis Technologies news, Director Tzu Yin Chiu sold 1,700 shares of the stock in a transaction dated Wednesday, February 1st. The shares were sold at an average price of $127.12, for a total transaction of $216,104.00. Following the sale, the director now directly owns 28,873 shares in the company, valued at $3,670,335.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Douglas A. Lawson sold 350 shares of the firm’s stock in a transaction dated Monday, November 28th. The shares were sold at an average price of $76.52, for a total transaction of $26,782.00. Following the completion of the transaction, the executive vice president now directly owns 34,038 shares in the company, valued at $2,604,587.76. The disclosure for this sale can be found here. Insiders have sold a total of 11,449 shares of company stock worth $995,462 in the last quarter. Corporate insiders own 2.15% of the company’s stock.

Axcelis Technologies Company Profile

(Get Rating)

Axcelis Technologies, Inc engages in the manufacture of capital equipment for the semiconductor chip manufacturing industry. It ion implantation systems product line includes high and medium current, and energy implanters. It also offers post-sales equipment service and support, such as spare parts, equipment upgrades, used equipment, maintenance services, and customer training.